Axios CEO Dr. Joseph Saba recently joined global healthcare leaders in Shanghai, China, for a discussion on ‘Challenges and Opportunities of Global Market Access for Pharmaceuticals’. Hosted by the China Europe International Business School (CEIBS), the panel explored ways to increase sustainable access to medicines in both emerging and developed markets, building on learnings from access-focused initiatives in China and across the globe, including: ☑️ What emerging markets can learn from access initiatives in developed countries and vice versa. ☑️ The need to rethink how market access is conducted in emerging markets to enable sustainable solutions. ☑️ There is no one-size-fits-all when it comes to access – differentiated strategies are key. ☑️ The importance of integrating market access considerations early in the product lifecycle to inform health technology assessment decisions. ☑️ The role of partnerships and digital health solutions in market access. Thank you to moderator Eric Bouteiller, panelists Dr. Xiaobin Wu, Jon Fairest, Professor Ding Jingxi, Dr. Vivian Chen, Paola Barbarino, as well Lou Garrison, for helping advance this important dialogue. We look forward to continuing to collaborate to put quality care and treatment within reach for more patients, regardless of where they live. 💻 Missed the session? Watch the full discussion on-demand here: https://lnkd.in/gJaTTTec
Axios International’s Post
More Relevant Posts
-
RESEARCH DOWN UNDER ▸ Over 32,000 clinical trials have been conducted down under in the past 25 years, showcasing Australia's critical role in global health innovation. 🔬 🌏 Increasingly recognised for its contributions to clinical research, Australia leverages strong regulatory frameworks, world-class research infrastructure, and diverse patient population to drive improvements in health innovation. 👩⚕️ Clinical research also contributes more than a billion dollars to the local economy each year and employs over 8,000 medical and research professionals. In support of the continued growth and innovation of the sector, Akesa is exhibiting at Society for Clinical Research Sites (SCRS)'s Australia & New Zealand Site Solutions Summit in Melbourne next week where industry experts will come together to discuss the latest trends and insights impacting research sites. 👋 Visit our booth to connect and share insights, and discover how Akesa can support your site needs. #Akesa #ANZSiteSolutionsSummit #BioTech #MedTech #HealthInnovation #ClinicalTrials #Networking 🌟
-
-
Scientist E & Mission In-Charge, Medical Device and Diagnostics Mission Secretariat (MDMS) & Head, Innovation & Translation Research Unit (ITR), Indian Council of Medical Research (ICMR), Hqrs, New Delhi, MoHFW, GoI
🎯 Strengthening Public Health through Innovation and Collaboration I was privileged to participate in the Regional Workshop on Capacity Building in Technology Transfer on Public-Health Oriented Intellectual Property Management and Licensing Models/Practices to Increase Access to Health Technologies, organized by World Health Organization South-East Asia. In the session, Policy Framework Promoting Innovation in Public Health for Access to Health Products, I shared insights on Technology Transfer activities in ICMR for public health, emphasizing strategies to bridge gaps in healthcare access through innovation. The workshop brought together esteemed participants from SEARO countries' Ministries of Health, Pharma, and Commerce, including representatives from Bangladesh, Nepal, Indonesia, Thailand, Sri Lanka, and India. Additionally, experts and TTO officials from WHO, WTO, NIH, and Netherland enriched the discussions with their global perspectives. Key contributors to the discussions included: Dr. Madhur Gupta, WHO Country Office, India Santosh Indraksha, Ph.D. CDSCO Maki Kajiwara, Global Centre for Traditional Medicine, WHO Tara Kirby, Office of Technology Transfer, NIH, USA Ram Siddappa, PhD, MBA, Leiden University and Medical Center Rubina Bose, CDSCO Siddhartha Prakash, Global Health & IP Division, WIPO A special acknowledgment to Dr Manisha Shridhar (WHO-SEARO), Dr. Madhur Gupta, (WHO Country Office India) and Vinita Jindal, PhD, RTTP, Registered Indian Patent Agent (BIRAC) for their pivotal roles in organizing this impactful event. Together, we explored policies and strategies to advance innovation, promote equitable access to medical products, and leverage intellectual property management for the greater good. Such collaborative platforms are essential to shaping the future of global health. A big thank you to World Health Organization South-East Asia for organizing this crucial dialogue! #PublicHealth #Innovation #TechnologyTransfer #GlobalHealth #ICMR #WHO
-
-
Asia's economy is in the fast lane, and the healthcare sector is soaring along with it. Unlocking this continent's immense growth potential is a core mission for Messe Düsseldorf GmbH. In a recent interview, Marius J. Berlemann, Chief Operating Officer, offers valuable insights and explains the strategic benefits of Messe Düsseldorf for Asia. ➡️ Read the full interview here: https://lnkd.in/gEk3BE-X Learn how we're empowering healthcare innovation across Asia and discover the milestones we've already achieved. Why MEDICARE ASIA? Global Reach: Connect with industry leaders from around the world. Cutting-Edge Innovations: Discover the latest medical technologies and solutions. Strategic Partnerships: Forge valuable connections to drive innovation. Stay ahead of the curve! Follow us for updates on upcoming MEDICARE ASIA events, where you can connect with industry leaders, discover cutting-edge solutions, and drive innovation in your organization. #healthcareinnovation #medicaltechnology #medicaldevice #biotech #pharma #healthcareindustry #digitalhealth #healthtech #futureofhealthcare #asiamarket #globalhealth #MesseDüsseldorf #MEDICAREASIA
-
The global distribution of clinical trials in 2023 reveals China and the US as leading regions in healthcare research, despite overall shifts in trial volumes. This year's data reflects a dynamic mapping of where and how clinical research efforts are being prioritized, offering a lens into the strategic focus areas within the healthcare sector. Explore the detailed breakdown of global and therapeutic insights in Citeline's comprehensive industry analysis: https://lnkd.in/gGzP7yTK #GlobalHealth #ClinicalTrials #ResearchTrends #HealthcareSector
-
-
Asset assessment for in licensing and out licensing, R&D, US FDA IND Regulatory Submission for BTD/ODD/AA, Global/local Clinical Studies, Board of Directors, International Speaker, CDP, M&A, Hiring, CME advice, Editor.
China and the US as leading regions in healthcare research, despite overall shifts in trial volumes. Reach out to the HiRO team to build the best strategy and execution plan for success globally. #HiRO #clinicaltrial #clinicaloperation #drugdevelopment #Citeline #Informa #CROselection #Faststartup #Operationexcellence #Medicalaffairs #Medicalwriting #Pharmacovigilance #Datamanagement #Projectmanagement #Regulatoryaffairs #Licensein #Innovation #patientcentricity
The global distribution of clinical trials in 2023 reveals China and the US as leading regions in healthcare research, despite overall shifts in trial volumes. This year's data reflects a dynamic mapping of where and how clinical research efforts are being prioritized, offering a lens into the strategic focus areas within the healthcare sector. Explore the detailed breakdown of global and therapeutic insights in Citeline's comprehensive industry analysis: https://lnkd.in/gGzP7yTK #GlobalHealth #ClinicalTrials #ResearchTrends #HealthcareSector
-
-
China’s healthcare market is now the second-largest in the world. 💡 With a rapidly ageing population, the challenges facing the healthcare sector in China provide many exciting opportunities for UK life science companies to collaborate in this dynamic sector. 🌏 Learn how to capitalise on the growing opportunities in market, navigate market access challenges and find suitable partners with expert insights from Department for Business and Trade (DBT), Dezan Shira & Associates (DSA) and ABHI. 🤝 Catch the highlights from our exclusive webinar 👇
Unlocking HealthTech Opportunities in China
https://vimeo.com/
-
Noteworthy update! On September 4 Justin Gandy, our Managing Director, MSD Polska, participated in the plenary session “CEE: New Leader in Digital Innovation” during the Economic Forum in Karpacz alongside the eminent speakers: - Krzysztof Gawkowski, Deputy Prime Minister, Minister of Digital Affairs, Ministerstwo Cyfryzacji - Aoife Houlihan, VP Government Engagement, Visa, Belgium - Stefan Andonovski, Minister, Ministry of Digital Transformation, North Macedonia The session was moderated by Piotr Wachowiak, Rector, Warsaw School of Economics, (SGH Warsaw School of Economics), Poland. The panelists were discussing the potential for Central and Eastern Europe (CEE) to become a global leader in digital innovation. With Poland standing out in open data and exceeding the EU average by 95%, the region is dynamically digitizing public services with a goal of full transformation by 2030. Having a speaker coming from innovative biopharmaceutical industry, the discussion could not skip the context of digitalization advancements in healthcare, emphasizing the importance of sharing trustworthy and unbiased medical knowledge as the key to a rational and harmonious cooperation among patients, medical services, and pharmaceutical business. On an example of vaccination monitoring dashboards, the discussion explored the potential of digital innovation that can equip healthcare providers and policymakers with data allowing them to make informed decisions on where to allocate resources and efforts to improve vaccination coverage. #DigitalInnovation #CEE #EconomicForumKarpacz #DigitalHealthcare Forum Ekonomiczne, #forumekonomiczne2024, #karpacz, #karpacz2024, #ochronazdrowia #Futureofhealth Pracodawcy RP, American Chamber of Commerce in Poland
-
-
Global medicine use is expected to grow significantly over the next five years. What regions will experience the highest volume of growth? 🌏China, India and Asia-Pacific IQVIA Institute’s Global Use of Medicines 2024: Outlook to 2028 found that global medicine use increased by 14% (or 414 billion defined daily doses) over the past five years, and is expected to grow another 12% by 2028. The driving force is increased global access to medicines. That’s why higher income regions will have lower volume growth. Areas such as North America, Western Europe and Japan are linked to more established health systems and existing access to medicine. Watch the webinar on-demand: https://bit.ly/49gfoPl. #IQVIAMIDAS #MarketPrognosis #ForecastLink #GlobalHealth #MedicineUse #GlobalUseofMedicines
-
-
[Local Insight] What to know about the Healthcare & Life Sciences industry in China in 2024? 🚑 With rapid growth and an increasing focus on health and well-being, China’s #healthcare industry is among the largest and fastest-growing sectors in the country. However, China is confronted with the challenges of an ageing population and a concerning lack of renewal, prompting a surge in demand for healthcare services. 🔸 Specialized medical facilities, such as nursing homes, are emerging to cater to the specific healthcare needs of the elderly population. 🔸Highly specialized medical institutions are proliferating in China, enhancing the quality of care provided to patients. 🔸 There is a growing emphasis on leveraging technology, such as AI, for early disease detection and long-term patient monitoring To know more, read the full article here 👉🏼 https://lnkd.in/esKvzvUX Contact our experts if you are considering #GlobalExpansion in China.
-
At this week's International Health Ministerial Summit in Rwanda, Roche's Dr Allan Pamba. Allan Pamba highlighted the critical role of partnerships, such as the collaboration between (RED) and Roche, in advancing access to diagnostics across Africa.
This week marks the inaugural International Health Ministerial Summit in Rwanda, a great thank you to Informa Markets for this one of a kind gathering. A significant thank you to the Honourable Minister Dr. Sabin Nsanzimana for opening Rwanda to host this critical conference as well as engaging with the Roche Diagnostics team in a bilateral session on areas of collaboration. We are much encouraged by the progress realised in Rwanda and are firmly committed to continuing on the path of collaboration and partnership to increase access to quality diagnostics for more people. In his opening remarks Dr Amit N. Thakker said “Collaboration is the new innovation”; this rings true for me, especially in Africa. With the barriers faced in driving equitable access to reliable testing, each stakeholder within the healthcare ecosystem has a valuable role to play in ensuring a healthier future for all Africans. In our session on ‘Strengthening diagnostics capacity in Africa – The power of partnerships’, we highlighted that only 20% of Africans have access to diagnostics. Nqobile Ndlovu MPH spoke about the need to amplify & listen to the voice of the community in the dialogue on how we close the diagnostics gap in Africa. Intentional collaborative efforts are required to speedily realise a holistic and sustainable approach to diagnostics access in Africa. Robust Government (MoH) stewardship is imperative. I also participated in a panel discussion on enabling Africa’s self-sufficiency from R&D, to locally manufactured Diagnostics & pharmaceuticals. Key prerequisites to attract these investments were highlighted. These include expediting regulatory harmonization among Africa’s emerging economic blocks, as well as accelerating trade agreements that open Africa’s borders for free movement of goods and people, read ‘The Africa Free Continental Trade Agreement’. Thank you to the honourable Dr Ibrahima SY, Health Minister Senegal, Dr. Ahmed Ogwell OUMA - FAPH, Nyawira Njeru, Dominic Wilhelm, MSc. and our moderator Philippe GERWILL on robust discussions, I look forward to engaging further in areas of collaboration.
